Gene · 4350
Papers2,085
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,085
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Damage Repair-Related Genes Signature for Immune Infiltration and Outcome in Cervical Cancer. | Front Genet | 2022 | 35309134 | PubTator, text mining | PubMed |
| Virulence Determinants in Staphylococcus aureus Clones Causing Osteomyelitis in Italy. | Front Microbiol | 2022 | 35308345 | PubTator, text mining | PubMed |
| A transcriptomic analysis based on aberrant methylation levels revealed potential novel therapeutic targets for nasopharyngeal carcinoma. | Ann Transl Med | 2022 | 35282089 | PubTator, text mining | PubMed |
| Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer. | Front Immunol | 2022 | 35273618 | PubTator, text mining | PubMed |
| Experiences of midwives on Vscan limited obstetric ultrasound use: a qualitative exploratory study. | BMC Pregnancy Childbirth | 2022 | 35272631 | PubTator, text mining | PubMed |
| Participation of Histones in DNA Damage and Repair within Nucleosome Core Particles: Mechanism and Applications. | Acc Chem Res | 2022 | 35271268 | PubTator, text mining | PubMed |
| Exosomal RNAs: Novel Potential Biomarkers for Diseases-A Review. | Int J Mol Sci | 2022 | 35269604 | PubTator, text mining | PubMed |
| Composition-Dependent Cytotoxic and Antibacterial Activity of Biopolymer-Capped Ag/Au Bimetallic Nanoparticles against Melanoma and Multidrug-Resistant Pathogens. | Nanomaterials (Basel) | 2022 | 35269267 | PubTator, text mining | PubMed |
| Atypical Properties of a Thin Silver Layer Deposited on a Composite Textile Substrate. | Materials (Basel) | 2022 | 35269045 | PubTator, text mining | PubMed |
| A Computational Text Mining-Guided Meta-Analysis Approach to Identify Potential Xerostomia Drug Targets. | J Clin Med | 2022 | 35268532 | PubTator, text mining | PubMed |
| Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted. | Cancers (Basel) | 2022 | 35267440 | PubTator, text mining | PubMed |
| Structures of the junctophilin/voltage-gated calcium channel interface reveal hot spot for cardiomyopathy mutations. | Proc Natl Acad Sci U S A | 2022 | 35238659 | PubTator, text mining | PubMed |
| Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma. | Front Genet | 2022 | 35237304 | PubTator, text mining | PubMed |
| Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay. | Microbiol Spectr | 2022 | 35225653 | PubTator, text mining | PubMed |
| A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer. | Front Immunol | 2022 | 35222383 | PubTator, text mining | PubMed |
| The Role of Natural Polymorphic Variants of DNA Polymerase β in DNA Repair. | Int J Mol Sci | 2022 | 35216513 | PubTator, text mining | PubMed |
| Emerging Concepts on the Role of Extracellular Vesicles and Its Cargo Contents in Glioblastoma-Microglial Crosstalk. | Mol Neurobiol | 2022 | 35212938 | PubTator, text mining | PubMed |
| Repair-Assisted Damage Detection Reveals Biological Disparities in Prostate Cancer between African Americans and European Americans. | Cancers (Basel) | 2022 | 35205762 | PubTator, text mining | PubMed |
| PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers. | Biomedicines | 2022 | 35203508 | PubTator, text mining | PubMed |
| A DNA repair-independent role for alkyladenine DNA glycosylase in alkylation-induced unfolded protein response. | Proc Natl Acad Sci U S A | 2022 | 35197283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4350/papers?page=19